Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05186623
Prediction Model for Response to Biologics and Small Molecular Agent for UC
Sponsor: Asan Medical Center
View on ClinicalTrials.gov
Summary
This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.
Official title: Establishment of Prediction Model of Biologics and Small Molecular Agent for Patients With Ulcerative Colitis Using Longitudinal Data
Key Details
Gender
All
Age Range
18 Years - 79 Years
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2022-02-05
Completion Date
2026-12-31
Last Updated
2022-02-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Vedolizumab, Ustekinumab, or Tofacitinib
Drug administration and prospective follow-up for evaluating response
Locations (1)
Asan Medical Center
Seoul, South Korea